These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 2758681

  • 1. Hydroxycholesterols in serum from hypercholesterolaemic patients with and without bile acid sequestrant therapy.
    van Doormaal JJ, Smit N, Koopman BJ, van der Molen JC, Wolthers BG, Doorenbos H.
    Clin Chim Acta; 1989 May 31; 181(3):273-9. PubMed ID: 2758681
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
    Day CE.
    Artery; 1990 May 31; 17(5):281-8. PubMed ID: 2396902
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
    Mordasini R, Twelsick F, Oster P, Schellenberg B, Raetzer H, Heuck CC, Schlierf G.
    Monatsschr Kinderheilkd (1902); 1978 Jul 31; 126(7):436-40. PubMed ID: 672910
    [Abstract] [Full Text] [Related]

  • 9. Effect of the bile-acid sequestrant colestipol on postprandial serum bile-acid concentration: evaluation by bioluminescent enzymic analysis.
    Rossi SS, Wayne ML, Smith RB, Wright CE, Andreadis NA, Hofmann AF.
    Aliment Pharmacol Ther; 1989 Feb 31; 3(1):41-6. PubMed ID: 2491457
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum 7 alpha-hydroxycholesterol reflects hepatic bile acid synthesis in patients with obstructive jaundice after external biliary drainage.
    Okamoto S, Fukushima K, Higashijima H, Makino I, Kishinaka M, Oda H, Yamashita H, Ichimiya H, Chijiiwa K, Kuroki S.
    Hepatology; 1994 Jul 31; 20(1 Pt 1):95-100. PubMed ID: 8020910
    [Abstract] [Full Text] [Related]

  • 12. Serum 27-hydroxycholesterol in patients with primary biliary cirrhosis suggests alteration of cholesterol catabolism to bile acids via the acidic pathway.
    Del Puppo M, Kienle MG, Petroni ML, Crosignani A, Podda M.
    J Lipid Res; 1998 Dec 31; 39(12):2477-82. PubMed ID: 9831637
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis.
    Glueck CJ.
    Ann Intern Med; 1982 Apr 31; 96(4):475-82. PubMed ID: 7039445
    [Abstract] [Full Text] [Related]

  • 20. Conversion of 7 alpha-hydroxycholesterol to bile acid in human subjects: is there an alternate pathway favoring cholic acid synthesis?
    Duane WC, Javitt NB.
    J Lab Clin Med; 2002 Feb 31; 139(2):109-15. PubMed ID: 11919549
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.